Key result
Cardiac magnetic resonance and fluorodeoxyglucose positron emission tomography successfully differentiated the contributions of left ventricular noncompaction and cardiac sarcoidosis to the patient's cardiomyopathy.
Case Report (n=1)
No
Advanced multimodality imaging with FDG-PET and CMR is valuable for diagnosing and defining the contributions of concurrent rare cardiomyopathies like LVNC and cardiac sarcoidosis.
May support multimodality imaging in overlapping cardiomyopathies; hypothesis-generating and requires validation.
A 60-year-old man with a history of heart failure received a diagnosis of left ventricular noncompaction (LVNC) and cardiac sarcoidosis (CS). Fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance defined the contribution of each uncommon condition to his heart failure. This case illustrates the role of imaging to aid diagnosis in the rare concurrence of LVNC and CS.
No takes yet. Share an insight, caveat, or question.
Tso et al. (2025) conducted a case report in Left ventricular noncompaction and cardiac sarcoidosis (n=1). Cardiac magnetic resonance (CMR) and fluorodeoxyglucose (FDG) positron emission tomography (PET) was evaluated. Cardiac magnetic resonance and fluorodeoxyglucose positron emission tomography successfully differentiated the contributions of left ventricular noncompaction and cardiac sarcoidosis to the patient's cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: